FAM160A2 Activators

FAM160A2 can influence this protein's function through various biochemical pathways. Phorbol 12-myristate 13-acetate, for instance, serves as a diacylglycerol analog, activating Protein Kinase C, which can lead to a phosphorylation cascade affecting multiple proteins, including FAM160A2. This phosphorylation can modify the activity state of FAM160A2, effectively leading to its functional activation. Similarly, Forskolin raises the levels of cAMP within the cell, thereby activating Protein Kinase A. This kinase is known for its ability to phosphorylate various substrates within the cell, and should it encounter FAM160A2, it can catalyze the transfer of a phosphate group to this protein, thus activating it. Ionomycin, by increasing intracellular calcium, can activate calcium-dependent protein kinases that are capable of phosphorylating FAM160A2, altering its activity state towards activation.

Calyculin A and Okadaic Acid prevent the dephosphorylation of proteins by inhibiting protein phosphatases such as PP1 and PP2A. This activity results in an overall increase in the phosphorylation levels of cellular proteins, which may include FAM160A2, thus promoting its activation by maintaining it in a phosphorylated state. Anisomycin activates stress-activated protein kinases, which, upon activation, could target FAM160A2 as a substrate for phosphorylation, resulting in its activation. Growth factors such as Epidermal Growth Factor and Vascular Endothelial Growth Factor initiate complex signaling cascades upon binding to their respective receptors. These cascades culminate in the activation of various kinases, some of which may be responsible for the phosphorylation and subsequent activation of FAM160A2. Insulin, through its receptor, can initiate the PI3K/Akt pathway, a well-established signaling pathway known for its role in modulating the activity of a broad range of proteins through phosphorylation, which may include the activation of FAM160A2. Isoproterenol, by activating adrenergic receptors, leads to a similar outcome as Forskolin, by increasing cAMP and activating PKA, which can then phosphorylate and activate FAM160A2. Lastly, 1,2-Dioctanoyl-sn-glycerol, another DAG mimetic, can activate PKC, leading to phosphorylation events that may activate FAM160A2, while BAY 11-7082, by inhibiting NF-κB activation, might lead to an altered phosphorylation landscape, thereby influencing the activation state of FAM160A2.